Today, nearly two million cancer cases are reported annually in India, with many patients requiring ongoing medication and treatment. A significant portion of these individuals come from middle-class and lower-income backgrounds, often facing immense financial strain due to the high costs of cancer drugs.
The new government initiative to reduce GST on cancer drugs from 12% to 5% is a commendable step in the right direction. This policy will further ease the financial burden on patients and their families, making life-saving treatments more accessible to those who need them most. This relief not only helps patients but also supports their families, who are equally affected by the emotional and mental toll of cancer care.
Reducing the cost of cancer treatment is not just a financial necessity; it's a step towards improving the overall mental health and well-being of millions of Indians. Every bit of financial relief can make a world of difference, offering hope and stability in the face of one of life's toughest battles.
Such measures are crucial in our collective fight against cancer, ensuring that no one is left behind due to financial constraints.